BaroFold
Aurora
About BaroFold
BaroFold is a privately held biopharmaceutical company focused on the development of commercially attractive protein therapeutics for immunology indications. The company's goal is to discover, develop and commercialize protein biologics, some of which incorporate its proprietary PreEMT™ high pressure folding technology along with other state-of-the-art technologies. This pipeline contains therapeutics with an Immunology focus, including Multiple Sclerosis, Rheumatoid Arthritis, and Asthma.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $17.4M
- Funding stage: M&A
- Last round: Series Unknown (Feb 2013)
- Website: barofold.com
- Phone: +1 303-926-0337
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/barofold-2898852 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.